Dermatology in Aventura, FL
17 verified dermatology doctors in Aventura.
Dermatologists treat conditions of the skin, hair, and nails, from acne and eczema to skin cancer screening.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Mark Nestor, MD
Dermatology
CMS Open Payments· $173,551 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$173,551
Total received
6
Transactions
4
Paying companies
Top paying companies
Among the 16,166 dermatology doctors we've analyzed, about 64% received any industry payment (median $642 among those who did). This doctor's total is higher than 98% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US dermatology doctors.
Payments to Mark Nestor do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Janet Teltscher, MD
Dermatology
CMS Open Payments· $40.53 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$40.53
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 16,166 dermatology doctors we've analyzed, about 64% received any industry payment (median $642 among those who did). This doctor's total is on the lower end — around the 41th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US dermatology doctors.
Payments to Janet Teltscher do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Barry Resnik, MD
Dermatology
CMS Open Payments· $12,863 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$12,863
Total received
67
Transactions
21
Paying companies
Top paying companies
Among the 16,166 dermatology doctors we've analyzed, about 64% received any industry payment (median $642 among those who did). This doctor's total is higher than 94% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US dermatology doctors.
Payments to Barry Resnik do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Brian Berman, MD
Dermatology
CMS Open Payments· $70,008 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$70,008
Total received
73
Transactions
10
Paying companies
Top paying companies
Among the 16,166 dermatology doctors we've analyzed, about 64% received any industry payment (median $642 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US dermatology doctors.
Payments to Brian Berman do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Loretta Ciraldo, MD
Dermatology
CMS Open Payments· $82.22 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$82.22
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 16,166 dermatology doctors we've analyzed, about 64% received any industry payment (median $642 among those who did). This doctor's total is on the lower end — around the 45th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US dermatology doctors.
Payments to Loretta Ciraldo do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Joel Wiszniak, MD
Dermatology
CMS Open Payments· $200.96 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$200.96
Total received
8
Transactions
5
Paying companies
Top paying companies
Among the 16,166 dermatology doctors we've analyzed, about 64% received any industry payment (median $642 among those who did). This doctor's total ranks around the 54th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US dermatology doctors.
Payments to Joel Wiszniak do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Carlos Cohen, MD
Dermatology
CMS Open Payments· $37.53 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$37.53
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 16,166 dermatology doctors we've analyzed, about 64% received any industry payment (median $642 among those who did). This doctor's total is on the lower end — around the 41th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US dermatology doctors.
Payments to Carlos Cohen do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Donna Bilu Martin, MD
Dermatology
CMS Open Payments· $293.37 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$293.37
Total received
11
Transactions
4
Paying companies
Top paying companies
Among the 16,166 dermatology doctors we've analyzed, about 64% received any industry payment (median $642 among those who did). This doctor's total ranks around the 58th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US dermatology doctors.
Payments to Donna Bilu Martin do not imply any wrongdoing. Many are meals, education, or research support.
Dr. David Drachman, MD
Dermatology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Marisa Potter, MD
Dermatology
CMS Open Payments· $16.40 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$16.40
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 16,166 dermatology doctors we've analyzed, about 64% received any industry payment (median $642 among those who did). This doctor's total is on the lower end — around the 37th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US dermatology doctors.
Payments to Marisa Potter do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Dorothy Koreman, MD
Dermatology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Dan Ilkovitch, MD
Dermatology
CMS Open Payments· $1,672 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,672
Total received
87
Transactions
20
Paying companies
Top paying companies
Among the 16,166 dermatology doctors we've analyzed, about 64% received any industry payment (median $642 among those who did). This doctor's total ranks around the 83th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US dermatology doctors.
Payments to Dan Ilkovitch do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Newsha Lajevardi, MD
Dermatology
CMS Open Payments· $476.09 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$476.09
Total received
14
Transactions
8
Paying companies
Top paying companies
Among the 16,166 dermatology doctors we've analyzed, about 64% received any industry payment (median $642 among those who did). This doctor's total ranks around the 64th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US dermatology doctors.
Payments to Newsha Lajevardi do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Angela Macri, MD
Dermatology
CMS Open Payments· $1,833 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,833
Total received
102
Transactions
21
Paying companies
Top paying companies
Among the 16,166 dermatology doctors we've analyzed, about 64% received any industry payment (median $642 among those who did). This doctor's total ranks around the 84th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US dermatology doctors.
Payments to Angela Macri do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Penelope Hirt, MD
Dermatology
CMS Open Payments· $1,068 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,068
Total received
42
Transactions
13
Paying companies
Top paying companies
Among the 16,166 dermatology doctors we've analyzed, about 64% received any industry payment (median $642 among those who did). This doctor's total ranks around the 75th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US dermatology doctors.
Payments to Penelope Hirt do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Brett Brazen, DO
Dermatology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Jezwah Harris, MD
Dermatology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.